Neue Konzepte in der Oberflächentherapie bei Verbrennungswunden

Zusammenfassung

Die Lokaltherapie von Verbrennungen nimmt einen hohen Stellenwert in der Versorgung von Brandverletzten ein. Ein Primärziel der Behandlung ist der Infektionsschutz der Hautoberfläche. Sekundärziele beinhalten die Wiederherstellung der Funktionalität und ästhetische Aspekte nach Ausheilung. Nach langjähriger Kontinuität in der Wundpflege Brandverletzter haben innerhalb der letzten Jahre einige Innovationen Eingang in die klinische Routine gefunden. So steht mit der Verwendung eines Wasserstrahlsystems eine neue Débridementtechnik zur Verfügung. Im Bereich des Hautersatzes bieten innovative Produkte wie Suprathel® und Matriderm® eine Erweiterung des Therapiespektrums. Seit ihrer Einführung in den Klinikalltag haben sich zahlreiche Publikationen mit diesen Neuerungen in der Lokaltherapie beschäftigt. Diese Arbeiten werden vorgestellt und kritisch mit den bestehenden Therapieregimen verglichen.

Abstract

Local burn wound care represents an integral part in the treatment of burn victims. A primary treatment goal is to prevent superficial infections, which can lead to life-threatening bacteraemia and sepsis. Secondary goals include improvement of functional and aesthetic outcome of the regenerating skin or scar tissue. Within the last few years numerous innovations have been evolved and some have already been incorporated into the clinical routine. In line with this, the first mid-term studies can be found in the literature. For instance, a hydrosurgical system can now be used for debridement and novel skin substitutes like Suprathel® and Matriderm® are commercially available. This review article summarises the most recent innovations in local burn wound care and puts them into a scientific perspective.

Schlüsselwörter

Hautersatz - Lokaltherapie - Verbrennungen

Key words

skin substitutes - local therapy - burns

Literatur

• 1 Argirova M, Hadjiski O, Victorova A. Acticoat versus Allevyn as a split-thickness skin graft donor-site dressing: a prospective comparative study.  Ann Plast Surg. 2007;  59 415-422
• 2 Cubison T C, Pape S A, Jeffrey S L. Dermal preservation using the Versajet hydrosurgery system for debridement of paediatric burns.  Burns. 2006;  32 714-720
• 3 Gravante G, Di Fede M C, Araco A. et al . A randomized trial comparing ReCell system of epidermal cells delivery versus classic skin grafts for the treatment of deep partial thickness burns.  Burns. 2007;  33 966-972
• 4 Gravante G, Delogu D, Esposito G. et al . Versajet hydrosurgery versus classic escharectomy for burn débridement: a prospective randomized trial.  J Burn Care Res. 2007;  28 720-724
• 5 Haslik W, Kamolz L P, Nathschläger G. et al . First experiences with the collagen-elastin matrix Matriderm® as a dermal substitute in severe burn injuries of the hand.  Burns. 2007;  33 364-368
• 6 Hauser J, Rossbach O, Vogt P M. et al . Efficacy of treatment with Repithel and Jelonet in comparison to treatment with Jelonet alone – a randomized clinical trial in patients receiving meshed skin grafts.  Zentralbl Chir. 2006;  131 315-321
• 7 Hauser J, Rossbach O, Langer S. et al . Local therapy of grade II a burns: Efficacy and tolerability of a new hydrosome wound gel for the local treatment of grade II a burns as compared with silver sulfadiazine ointment.  Unfallchirurg. 2007;  110 988-994
• 8 Huang Y, Li X, Liao Z. et al . A randomized comparative trial between Acticoat and SD‐Ag in the treatment of residual burn wounds, including safety analysis.  Burns. 2007;  33 161-166
• 9 Janzekovic Z. A new concept in the early excision and immediate grafting of burns.  J Trauma. 1970;  10 1103-1108
• 10 Janzekovic Z. The burn wound from the surgical point of view.  J Trauma. 1975;  15 42-61
• 11 Kamolz L P, Andel H, Haslik W. et al . Use of subatmospheric pressure therapy to prevent burn wound progression in human: first experiences.  Burns. 2004;  30 253-258
• 12 Kamolz L P, Lumenta D B, Kitzinger H B. et al . Tissue engineering for cutaneous wounds: an overview of current standards and possibilities.  Eur Surg. 2008;  40 19-26
• 13 Klein M B, Hunter S, Heimbach D M. et al . The Versajet water dissector: a new tool for tangential excision.  J Burn Care Rehabil. 2005;  26 483-487
• 14 Morykwas M J, David L R, Schneider A M. et al . Use of subatmospheric pressure to prevent progression of partial-thickness burns in a swine model.  J Burn Care Rehabil. 1999;  20 15-21
• 15 Rennekampf H O, Schaller H E. Debridement of burn wounds with a water jet surgical tool.  Burns. 2006;  32 64-69
• 16 Rosenberg L, Lapid O, Bogdanov-Berezovsky A. et al . Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report.  Burns. 2004;  30 843-850
• 17 Ryssel H, Gazyakan E, Germann G. et al . The use of MatriDerm® in early excision and simultaneous autologous skin grafting in burns – A pilot study.  Burns. 2008;  34 93-97
• 18 Schwarze H, Küntscher M, Uhlig C. et al . Suprathel, a new skin substitute, in the management of donor sites of split-thickness skin grafts: results of a clinical study.  Burns. 2007;  33 850-854
• 19 Schwarze H, Küntscher M, Uhlig C. et al . Suprathel, a new skin substitute, in the management of partial-thickness burn wounds: results of a clinical study.  Ann Plast Surg. 2008;  60 181-185
• 20 Uhlig C, Rapp M, Hartmann B. et al . Suprathel – an innovative, resorbable skin substitute for the treatment of burn victims.  Burns. 2007;  33 221-229
• 21 Uhlig C, Rapp M, Dittel K K. Neue Strategien zur Behandlung thermisch geschädigter Hände unter Berücksichtigung des Epithelersatzes Suprathel®.  Handchir Mikrochir Plast Chir. 2007;  39 314-319
• 22 Ulkür E, Oncül O, Karagöz H. et al . Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5 % (Bactigrass), and silver sulfadiazine 1 % (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.  J Burn Care Rehabil. 2005;  26 430-433
• 23 Ulkür E, Oncül O, Karagöz H. et al . Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5 % (Bactigrass), and fusidic acid 2 % (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.  Burns. 2005;  31 874-877
• 24 van Zuijlen P P, van Trier A J, Vloemans J F. et al . Graft survival and effectiveness of dermal substitution in burns and reconstructive surgery in a one-stage grafting model.  Plast Reconstr Surg. 2000;  106 615-623
• 25 Varas R P, O'Keeffe T, Namias N. et al . A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful?.  J Burn Care Rehabil. 2005;  26 344-347
• 26 Vlachou E, Chipp E, Shale E. et al . The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption.  Burns. 2007;  33 979-985
• 27 Vogt P M, Reimer K, Hauser J. et al . PVP-iodine in hydrosomes and hydrogel – a novel concept in wound therapy leads to enhanced epithelialization and reduced loss of skin grafts.  Burns. 2006;  32 698-705
• 28 Vogt P M, Kolokythas P, Niederbichler A. et al . Innovative wound therapy and skin substitutes for burns.  Chirurg. 2007;  78 335-342
• 29 Zweifel C J, Contaldo C, Köhler C. et al . Initial experiences using non-cultured autologous keratinocyte suspension for burn wound closure. Initial experiences using non-cultured autologous keratinocyte suspension for burn wound closure.  J Plast Reconstr Aesthet Surg. 2007;  DOI: 10.1016/j.bjps.2007.07.015